Am J Transplant, Volume 19, Suppl 3 Archives - Page 203 of 214 - ATC Abstracts

2019 American Transplant Congress
Outcomes of Phenotypes in Early Subclinical Inflammation (SCI) Determined by Presence of Interstitial Inflammation with or without Concomitant Tubulitis
R. Mehta, S. Tandukar, D. Jorgensen, I. Owoyemi, P. Sood, A. Tevar, S. Hariharan
University of Pittsburgh Medical Center, Pittsburgh, PA
*Purpose: Low levels of renal allograft inflammation in the early post transplant period appear to have an impact on renal architecture and function. However, the…
2019 American Transplant Congress
Use of GLP-1 Receptor Agonists in Kidney Transplant Recipients with Type 2 Diabetes
A. Kukla, J. Hill, M. Merzkani, A. Bentall, E. Lorenz, W. Park, P. Shah, N. Issa, M. Stegall
Mayo Clinic, Rochester, MN
*Purpose: GLP-1 receptor agonists have been shown to improve glucose control and diabetes-related comorbidities, including obesity, cardiovascular disease and chronic kidney disease, in non-transplant patients.…
2019 American Transplant Congress
Tacrolimus Activated BMP Signaling Acts in Synergy with Stress-Activated FOXO1 to Induce Loss of Beta-Cell Function and Identity
J. Trinañes¹, P. ten Dijke², T. J. Rabelink³, E. J. de Koning⁴, F. Carlotti¹, A. P. de Vries¹
¹Transplant Center, Leiden University Medical Center, Leiden, Netherlands, ²Molecular Cell Biology, Leiden University Medical Center, Leiden, Netherlands, ³of Nephrology, Leiden University Medical Center, Leiden, Netherlands, ⁴Nephrology, Leiden University Medical Center, Leiden, Netherlands
*Purpose: Tacrolimus, the most widely used immunosuppressive drug, is known to be highly diabetogenic. It is thought to trigger β-cell death through inhibition of the…
2019 American Transplant Congress
Intracerebral Hemorrhage in Renal Transplant Recipients with Autosomal Dominant Polycystic Kidney Disease: A Nationwide Analysis
W. Cheungpasitporn¹, C. Thongprayoon², P. Ungprasert³, K. Wijarnpreecha⁴, F. T. Chebib², P. T. Kroner⁴
¹Division of Nephrology, Department of Medicine, University of Mississippi Medical Center, Jackson, MS, ²Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, MN, ³Clinical Epidemiology Unit, Department of Research and Development, Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand, ⁴Department of Medicine, Mayo Clinic, Jacksonville, FL
*Purpose: This study aimed to evaluate the hospitalization rate for intracerebral hemorrhage (ICH) among renal transplant patients with adult polycystic kidney disease (ADPKD) and its…
2019 American Transplant Congress
HLA-DR Upregulation in Pediatric Kidney Transplant Biopsies
O. Moussa, S. Self, E. Bruner, K. Twombley
Medical University of South Carolina, Charleston, SC
*Purpose: Renal tubular epithelial cells do not typically express human leukocyte antigen DR (HLA-DR). It’s expression has been associated with different types of tubular injury…
2019 American Transplant Congress
Differences in Graft Survival for Pediatric and Adult Kidney Recipients Followed and Lost to Follow-Up
A. M. Robinson¹, E. K. Hsu², S. M. Bartosh³, D. E. Stewart¹, G. V. Mazariegos⁴
¹United Network for Organ Sharing, Richmond, VA, ²Seattle Children's Hospital, Seattle, WA, ³University of Wisconsin Hospital and Clinics, Madison, WI, ⁴Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA
*Purpose: While the majority of kidney transplant recipients are followed by their program, many end up reported to the OPTN as lost to follow-up (LTFU).…
2019 American Transplant Congress
Development of De Novo Antibody in Renal Transplant Recipients with BK Viremia Managed with Immunosuppression Reduction
M. Raijmakers¹, A. Shetty², R. Hod Dvorai², A. Tambur², M. G. Ison²
¹University of Santiago, Santiago, Chile, ²Northwestern University Comprehensive Transplant Center, Chicago, IL
*Purpose: To determine the development of de novodonor specific antibodies (DSA) in renal transplant recipients with immunosuppression modulation and BK viremia and the associated risk…
2019 American Transplant Congress
Finding Opportunities for Increased Donation after Circulatory Death Liver Utilization: Results of an American Society of Transplant Surgeons/Association of Organ Procurement Organizations Survey
M. Hobeika¹, R. Glazner², D. Foley¹, S. Hanish¹, C. Quintini¹, E. Eidbo², D. Axelrod¹
¹American Society of Transplant Surgeons DCD Task Force, Arlington, VA, ²Association of Organ Procurement Organizations, Vienna, VA
*Purpose: Liver allografts from donation after circulatory death (DCD) donors remain underutilized in the U.S. Improved utilization requires expanded potential donor identification by organ procurement…
2019 American Transplant Congress
Factors Associated with the Acceptance of Livers for Liver Transplantation: Validation of the Discard Risk Index in the Eurotransplant Region
J. D. Boer¹, H. Putter², J. J. Blok³, N. Cambridge¹, S. Van den Berg¹, U. Samuel¹, G. Berlakovich⁴, M. Guba⁵, A. E. Braat³
¹Eurotransplant International Foundation, Leiden, Netherlands, ²Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, Netherlands, ³Transplant Center, Leiden University Medical Center, Leiden, Netherlands, ⁴Medical University of Vienna, Vienna, Austria, ⁵Hospital of the University of Munich, Munich, Germany
*Purpose: In times of organ shortage it has to be better understood why available livers are not transplanted. This study aims to analyze factors associated…
2019 American Transplant Congress
Deceased Donor Predictors for Pediatric Liver Allograft Utilization and Outcome of the Use of Paediatric Donor Livers in Adult Recipients
S. Huang, C. Sun, X. He, Z. Guo, G. Chen
Organ Transplant Center, the First Affiliated Hospital of SYSU, Guangzhou, China
*Purpose: We determined to find out the utilization rate of pediatric livers, identify risk factors for graft discard and analyse the outcomes of adult liver…